Immune sensor ZBP1 links interferon treatment and dangerous inflammatory cell death during COVID-19
Nationwide study of hospitalizations finds percutaneous coronary intervention is safe for cardio-oncology patients
19 May 2022How have changes in anemia care affected patients with kidney failure?
19 May 2022Immune sensor ZBP1 links interferon treatment and dangerous inflammatory cell death during COVID-19
Scientists from St. Jude Children’s Research Hospital have shown that the innate immune sensor, ZBP1, and its associated inflammatory cell death pathway, PANoptosis, are major contributors to the negative effects of interferon treatment and high interferon levels in some COVID-19 patients. The work was published today in Science Immunology.
